¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2024 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-22

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2024 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-22
±³À°ÀÏÀÚ : 2024-06-22
±³À°Àå¼Ò : ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ ÄÁº¥¼ÇȦ4F

±³À°ÁÖÁ¦ : 2024 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ (2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѾȰúÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : Çѱ¹¸Á¸·ÇÐȸ

´ã´çÀÚ : ¹ÚÀ±Á¤
¿¬¶ôó : 02-471-6520

À̸ÞÀÏ : retina@retina.or.kr

±³À°Á¾·ù : ¾È°ú

Âü¼®¿¹»óÀÎ : 170¸í
Èñ¸ÁÆòÁ¡ : 1Á¡

Áö¿ª : ±¤ÁÖ±¤¿ª½Ã
±³À°½Ã°£ : 1 ½Ã°£ 36ºÐ

¼¼ºÎ¼ö°­·á : 50,000¿ø  

ºñ°í


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 09:00~09:08 (ÃÊ·Ï)Asian Subgroup Analysis of a Phase III Study Comparing SB15 with Reference Aflibercept (Eylea) in Neovascular Age-related Macular Degeneration ÀÌÁÖ¿ë(¼­¿ï¾Æ»êº´¿ø)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 09:08~09:16 (ÃÊ·Ï)Real-world incidence and risk factors of incident non-infectious uveitis in patients treated with Immune checkpoint inhibitors ±è¿ëÁØ(¿¬¼¼´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 09:16~09:24 (ÃÊ·Ï)Progression of myopia and related structural changes in retina: school-based prospective cohort study ¹è°ÇÈ£(¼­¿ï´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 09:24~09:32 (ÃÊ·Ï)Cost-effectiveness of the anti-vascular endothelial growth factor intravitreal injection and panretinal photocoagulation for patients with proliferative diabetic retinopathy in South Korea Áöµ¿Çö(°¡Å縯´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 09:32~09:40 (ÃÊ·Ï)Case series of branch retinal vein occlusion secondary to rhegmatogenous retinal detachment and its surgical management ¹Ú¼ºÈÄ(ºÎ»ê´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 09:40~09:48 (ÃÊ·Ï)Prevalence and Risk Factors of Age-related Macular Degeneration in South Korea: Korea National Health and Nutrition Examination Survey 2017-2020 ±èÀçÈÖ(±è¾È°úº´¿ø)

ÈÞ½Ä 06¿ù 22ÀÏ 09:48~09:55 ÈÞ½Ä -(-)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 09:55~10:03 (ÃÊ·Ï)Introducing New Retinal Vessel Analysis Software: SEoul Retinal Vessel Assessment Library (SERVAL) ¹Ú»óÁØ(¼­¿ï´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 10:03~10:11 (ÃÊ·Ï)Multimodal deep learning-based prediction of treatment response in diabetic macular edema À±Á¦¹®(¼º±Õ°ü´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 10:11~10:19 (ÃÊ·Ï)A novel fluorescent diagnostic agent targeting choroidal neovascularization Ãֽ¿ì(¼­¿ï´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 10:19~10:27 (ÃÊ·Ï)Epiretinal Membrane: Exploring Correlations between Clinical and immunohistochemical Characteristics and Their Prognostic Implications ¾çÇö½Â(¼­¿ï½Å¼¼°è¾È°ú)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 10:27~10:35 (ÃÊ·Ï)Changes in the outer nuclear layer and choroidal vascularity during the manifest and quiescent phases of acute central serous chorioretinopathy ¼­ÀÇÁ¾(ÃæºÏ´ë)

±³À°½Ã°£ 06¿ù 22ÀÏ 4F ÄÁº¥¼ÇȦ 10:35~10:43 (ÃÊ·Ï)Macular microvasculature asymmetry in high myopia patients with open-angle glaucoma À̹οì(°Ç¾ç´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2024 Çѱ¹¸Á¸·ÇÐȸ ÇÏ°èÇмú´ëȸ (2ÀÏÂ÷) : 2024-06-22""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û (¿Â¶óÀÎ) Á¦7ȸ ºÐ´ç¼­¿ï´ëÇб³º´¿ø ¾îÁö·³Áõ¼¾ÅÍ ¿¬¼ö°­Á : 2024-06-22
´ÙÀ½±Û ´ëÇÑÃé´ãµµÇÐȸ [¿Â¶óÀÎ] Pancreato-Biliary Summer School 2024 (PB-SS) : 2024-06-22
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
78 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø Á¦7ȸ ¿°Áõ¼º ÀåÁúȯ ¼¾ÅÍ ½ÉÆ÷Áö¾ö : 2018-08-19 0 325 2018-07-28
77 ±¤ÁÖ Á¦30Â÷ ´ëÇÑ·ù¸¶Æ¼½ºÇÐȸ ¿¬¼ö°­Á : 2018-08-19 0 739 2018-07-28
76 ¼­¿ï »ï¼º¼­¿ïº´¿ø Á¦ 3ȸ Current Concepts and Techniques In Knee Surgery (CCTIKS) -SMC Live Surgery & Symposium- : 2018-08-19 0 652 2018-07-28
75 ¼­¿ï 2018 °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ »êºÎÀΰú ¿¬¼ö°­Á : 2018-08-19 0 791 2018-07-28
74 ºÎ»ê 2018³â ´ëÇѼÒÈ­±â¿¬°üÇÐȸ ºÎ¿ï°æÁöȸ ¿¬¼ö°­Á : 2018-08-19 0 895 2018-07-28
73 ´ë±¸ ´ëÇѳ»°úÇÐȸ Á¦18ȸ ³»°úÀü¹®ÀÇ Æò»ý±³À° ¿¬¼ö°­Á : 2018-08-19 0 504 2018-07-28
72 ¼­¿ï ´ëÇѼҾÆû¼Ò³âÁ¤½ÅÀÇÇÐȸ 2018³âµµ ¼ºÀÎADHD¿¬±¸È¸ "¼ºÀÎ ADHD Áø·áÀÇ ½ÇÀü ±æ¶óÀâÀÌ" : 2018-08-19 0 844 2018-07-28
71 ¼­¿ï Á¦3ȸ ´ëÇѼҾÆû¼Ò³â°úÀÇ»çȸ ÃÊÀ½ÆÄ¿öÅ©¼¥ : 2018-08-19 0 606 2018-07-28
70 ¼­¿ï ´ëÇѺñ°úÇÐȸ RHINOLOGY UPDATE SYMPOSIUM IN 2018 : 2018-08-18 0 464 2018-07-28
69 ´ë±¸ 2018³âµµ ´ëÇѽŰæ¿Ü°úÇÐȸ ´ë±¸¡¤°æºÏÁöȸ Á¦3Â÷ ¿¬¼ö±³À° : 2018-08-18 0 456 2018-07-28
68 °æ±â 2018 °í·Á´ëÇб³¾È»êº´¿ø °¡Á¤ÀÇÇаú °³¿øÀÇ ¿¬¼ö°­Á : 2018-08-18 0 693 2018-07-28
67 ¼­¿ï ¼­¿ï´ëÇб³º´¿ø Highlighted Access on Disease Recurrence Of Cervical cancer(HADROC) Symposium : 2018-08-18 0 604 2018-07-28
66 ¼­¿ï 2018 ´ëÇѽÉÆóÇ÷°ü¸¶ÃëÇÐȸ ¿¬¼ö°­Á : 2018-08-18 0 576 2018-07-28
65 ¼­¿ï 2018 ´ëÇѽÉÆóÇ÷°ü¸¶ÃëÇÐȸ TEE Workshop : 2018-08-18 0 723 2018-07-28
64 ºÎ»ê ´ëÇѽɺÎÀüÇÐȸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2018-08-18 0 578 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409 | 1410
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷